GLP-1 RAs Cost-Effective Versus Usual Care for Knee OA, Obesity

WEDNESDAY, Sept. 17, 2025 (HealthDay News) -- Compared with usual care, the glucagon-like peptide 1 receptor agonists (GLP-1 RAs) tirzepatide and semaglutide ar